Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last
Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last year's RadiologicalSociety of North America meeting, uses a unique short-geometrydesign to save space. Elscint plans to begin international deliveriesof SeleCT/SP in the third quarter, with U.S. shipments startingin the fourth quarter.
In other SeleCT/SP news, Elscint signed an agreement with BirlaMedical Technologies of India in which BMT will assemble SeleCT/SPunder license for sale in the Indian market. BMT expects to beginassembling SeleCT/SP scanners in a factory near New Delhi laterthis year.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).